[18-F]-FCH
Showing 1 - 25 of >10,000
Brain Metastases Trial in New York (18F-FCH PET Scan)
Completed
- Brain Metastases
- 18F-FCH PET Scan
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 15, 2022
18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)
Active, not recruiting
- 18F-fluorocholine
- +2 more
- [F-18]-FCH PET/MRI
-
Toronto, Ont, CanadaUHN
Dec 9, 2022
Hepatocellular Carcinoma Non-resectable Trial in Honolulu (Fluorine-18 fluorocholine)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Fluorine-18 fluorocholine
-
Honolulu, HawaiiThe Queen's Medical Center
Mar 28, 2022
Myeloma Multiple Trial in Pessac (Positron Emission Tomography using 18F-FCH, Positron Emission Tomography using 18F-FDG)
Recruiting
- Myeloma Multiple
- Positron Emission Tomography using 18F-FCH
- Positron Emission Tomography using 18F-FDG
-
Pessac, FranceBordeaux University Hospital - Haut-Lévêque
Mar 30, 2022
Multiple Myeloma Trial in Besançon, Dijon (FDG and FCH PET/CT)
Recruiting
- Multiple Myeloma
- FDG and FCH PET/CT
-
Besançon, France
- +2 more
Mar 24, 2022
Fluorocholine PET/CT Trial (18F-fluorocholine PET/CT.)
Not yet recruiting
- Fluorocholine PET/CT
- 18F-fluorocholine PET/CT.
- (no location specified)
Oct 24, 2022
Prostate Cancer Trial in Australia, Canada, United Kingdom (18F-FCH PET/MRI Scan)
Completed
- Prostate Cancer
- 18F-FCH PET/MRI Scan
-
Sydney, New South Wales, Australia
- +9 more
Apr 4, 2022
An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene
Recruiting
- Prostate Cancer
- +2 more
- MRI pelvis or CT imaging
- +2 more
-
London, Sutton, Surrey, United KingdomCancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022
Hyperparathyroidism, Parathyroid Adenoma Trial (We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of
Completed
- Hyperparathyroidism
- Parathyroid Adenoma
- We assessed sensitivity of 18F-FCH PET/CT in preoperative localisation of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism
- (no location specified)
Sep 25, 2020
Prostate Cancer Trial in Tripler AMC (Fluourine-18 Fluoromethylcholine PET/CT Imaging)
Completed
- Prostate Cancer
- Fluourine-18 Fluoromethylcholine PET/CT Imaging
-
Tripler AMC, HawaiiTripler Army Medical Center
Jul 19, 2022
F18-MHF: Orthopedic Implants-Associated Infection Detection
Not yet recruiting
- Knee Disease
- Knee Infection
-
Atlanta, GeorgiaEmory University Hospital
May 25, 2023
Advanced Non Small Cell Lung Cancer Trial ([18F]F-AraG)
Not yet recruiting
- Advanced Non Small Cell Lung Cancer
- (no location specified)
Oct 24, 2023
Endometriosis Trial in Rochester (F-18 FES)
Enrolling by invitation
- Endometriosis
- F-18 FES
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 17, 2022
NSCLC Trial in Iowa City ([18F]F-ARAG PET)
Not yet recruiting
- Non-small Cell Lung Cancer
- [18F]F-ARAG PET
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Oct 10, 2023
Oncology, Prostate Cancer Trial in Edmonton ([18]F-PSMA-1007)
Not yet recruiting
- Oncology
- Prostate Cancer
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jan 25, 2023
Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,
Recruiting
- Breast Carcinoma
- +7 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 24, 2022
Amyloidosis Trial in Rochester (18-F Florbetapir PET/MR scan)
Enrolling by invitation
- Amyloidosis
- 18-F Florbetapir PET/MR scan
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Congenital Hyperinsulinism, Insulinoma Trial in Fort Worth (Fluorodopa F 18)
Recruiting
- Congenital Hyperinsulinism
- Insulinoma
- Fluorodopa F 18
-
Fort Worth, TexasCook Children's Medical Center
Dec 8, 2022
Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron
Recruiting
- Intracranial Neoplasm
- +4 more
- F-18 Fluoroethyltyrosine (FET)
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 7, 2022
Glioma Trial in Portland (Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging)
Not yet recruiting
- Glioma
- Fludeoxyglucose F-18
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 30, 2023
An Imaging Agent With Positron Emission Tomography/Magnetic
Recruiting
- Recurrent Soft Tissue Sarcoma
- +2 more
- Fluorodopa F 18
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
18F-TFB PET/CT Scan in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Gland Carcinoma
- +2 more
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,
Recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- Metastatic Malignant Neoplasm in the Spine
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 13, 2022
Advanced Stage NSCLC Trial in Amsterdam ([18F]F-AraG PET scan)
Recruiting
- Advanced Stage Non-small Cell Lung Cancer
- [18F]F-AraG PET scan
-
Amsterdam, NetherlandsAmsterdam UMC, location VU University Medical Center
Jan 17, 2023